AnodyneWiki

1-Benzylpiperazine

BZP, 1-BZP
1-Benzylpiperazine
Molecular structure via molpic based on CDK
Rotamer
[]
Conformer structure via 3Dmol.js
Enable javascript to view conformer structure via 3Dmol.js
Physical properties
[]
176.26 g/mol [1]
1.3 [1]
Structural Identifiers
[]
C11H16N2 [1]
1-benzylpiperazine [1]
C1CN(CCN1)CC2=CC=CC=C2 [1]
InChI=1S/C11H16N2/c1-2-4-11(5-3-1)10-13-8-6-12-7-9-13/h1-5,12H,6-10H2 [1]
InChIKeyIQXXEPZFOOTTBA-UHFFFAOYSA-N [1]
Pharmacokinetics[]
Elimination half-life5.5 Hours

1-Benzylpiperazine (also known as Benzylpiperazine, N-benzylpiperazine, 4-Benzylpiperazine, Piperazine, 1-(phenylmethyl)-, NSC-40889, J149.807J, Dtxsid0022197, Chebi:83537, BZP cpd or Egyt-2760) is a stimulant substance of the 1-benzylpiperazine class.

Chemistry

 []

1-Benzylpiperazine is a achiral mixture.

Subjective effects []

Experience reports []

 []

  • Australia: 1-Benzylpiperazine is a Schedule 9 substance.
  • Brazil: 1-Benzylpiperazine is a F2 substance.[3]
  • Canada: 1-Benzylpiperazine is a Schedule III substance.
  • Germany: 1-Benzylpiperazine is a Anlage II substance.
  • New Zealand: 1-Benzylpiperazine is a Class C substance.
  • United Kingdom: 1-Benzylpiperazine is a prescription only substance.
  • United States: 1-Benzylpiperazine is a Schedule I under the "Controlled Substances Act (CSA)".

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 75994, 1-Benzylpiperazine. Accessed May 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/75994

  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 1-Benzylpiperazine. UNII: 3UG152ZU0E. Global Substance Registration System. Accessed May 8, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/3UG152ZU0E

  3. Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed May 8, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451